The first trial has gone badly, your company's product is threatened with even more litigation, and though your scientists are sure the product is safe, there are no definitive studies to counter the plaintiffs' experts' speculative opinions. Is it a good idea to conduct company-sponsored studies to disprove the plaintiffs' theories and assist the company in winning lawsuits? The short answer: Weigh the risks, according to Crowell & Moring's William Anderson and Michael Martinez.
December 22, 2005 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Presented by BigVoodoo
This event shines a spotlight on the individuals, teams, projects and organizations that are changing the financial industry.
BTI provides leading tax professionals from financial institutions with unmatched tools and resources.
Honoring outstanding legal achievements focused at the national level, largely around Big Law and in-house departments.
CORE RESPONSIBILITIES AND TASKS:(1) Tasks and responsibilities include:Reviewing and negotiating commercial agreements for internal business...
Boutique midtown Manhattan law firm specializing in sophisticated real estate litigation & representation of commercial and residential ...
Description: Fox Rothschild has an opening in the Boston, MA office for a Litigation Associate with 3 to 5 years of experience. The ideal ca...
